Among hit compounds, a commercially available and assessable compound, Chicoric acid, was purchased to evaluate its anti-cancer potential against PHGDH overexpressing gastric cancer cell line MGC-803 and SGC-7901. This evidence concerns the gene PHGDH and gastric cancer.